Iron induces cancer stem cells and aggressive phenotypes in human lung cancer cells

American Journal of Physiology - Cell Physiology

Volumn 310, Issue 9, 2016, Pages C728-C739

  Chanvorachote, Pithi ^a   Luanpitpong, Sudjit ^a,b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Cancer stem cells; Hydroxyl radical; Iron; Lung cancer; SOX9

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; HYDROXYL RADICAL; IRON; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR SOX9; TUMOR MARKER; SOX9 PROTEIN, HUMAN;

ARTICLE; CANCER STEM CELL; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC MANIPULATION; HUMAN; HUMAN CELL; IRON BALANCE; IRON THERAPY; LUNG CANCER CELL LINE; NON SMALL CELL LUNG CANCER; OXIDATION; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; RNA INTERFERENCE; TUMOR GROWTH; TUMOR INVASION; TUMOR SPHEROID; UPREGULATION; CARCINOGENESIS; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CARCINOGENESIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; HUMANS; HYDROXYL RADICAL; IRON; LUNG NEOPLASMS; NEOPLASTIC STEM CELLS; PHENOTYPE; SOX9 TRANSCRIPTION FACTOR;

EID: 84983627794     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00322.2015     Document Type: Article

References (54)

1. Abubaker K, Latifi A, Luwor R, Nazaretian S, Zhu H, Quinn MA, Thompson EW, Findlay JK, Ahmed N. Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden. Mol Cancer 12: 24, 2013.
2. Ailles LE, Weissman IL. Cancer stem cells in solid tumors. Curr Opin Biotechnol 18: 460–466, 2007.
3. Aleman A, Adrien L, Lopez-Serra L, Cordon-Cardo C, Esteller M, Belbin TJ, Sanchez-Carbayo M. Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays. Br J Cancer 98: 466–473, 2008.
4. Asou Y, Nifuji A, Tsuji K, Shinomiya K, Olson EN, Koopman P, Noda M. Coordinated expression of scleraxis and Sox9 genes during embryonic development of tendons and cartilage. J Orthop Res 20: 827–833, 2002.
5. Bacac M, Stamenkovic I. Metastatic cancer cell. Annu Rev Pathol 3: 221–247, 2008.
6. Baz MA, Ghio AJ, Roggli VL, Tapson VF, Piantadosi CA. Iron accumulation in lung allografts after transplantation. Chest 112: 435–439, 1997.
7. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabro E, Pastorino U, Sozzi G. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA 106: 16281–16286, 2009.
8. Biddle A, Liang X, Gammon L, Fazil B, Harper LJ, Emich H, Costea DE, Mackenzie IC. Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. Cancer Res 71: 5317–5326, 2011.
9. Bystrom LM, Guzman ML, Rivella S. Iron and reactive oxygen species: friends or foes of cancer cells? Antioxid Redox Signal 20: 1917–1924, 2014.
10. Capaccione KM, Hong X, Morgan KM, Liu W, Bishop JM, Liu L, Markert E, Deen M, Minerowicz C, Bertino JR, Allen T, Pine SR. Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma. Oncotarget 5: 3636–3650, 2014.
11. Chung-man HJ, Zheng S, Comhair SA, Farver C, Erzurum SC. Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res 61: 8578–8585, 2001.
12. Cronin JC, Watkins-Chow DE, Incao A, Hasskamp JH, Schonewolf N, Aoude LG, Hayward NK, Bastian BC, Dummer R, Loftus SK, Pavan WJ. SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis. Cancer Res 73: 5709–5718, 2013.
13. Cutz E. Idiopathic pulmonary hemosiderosis and related disorders in infancy and childhood. Perspect Pediatr Pathol 11: 48–81, 1987.
14. Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concept. Annu Rev Med 58: 267–284, 2007.
15. Dong C, Wilhelm D, Koopman P. SOX genes and cancer. Cytogenet Genome Res 105: 442–447, 2004.
16. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kamamura MF, Wicha MS. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253–1270, 2003.
17. Gavert N, Vivanti A, Hazin J, Brabletz T, Ben-Ze’ev A. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers. Mol Cancer Res 9: 14–24, 2011.
18. Ghio AJ, Roggli VL, Soukup JM, Richards JH, Randell SH, Muhlebach MS. Iron accumulates in the lavage and explanted lungs of cystic fibrosis patients. J Cyst Fibros 12: 390–398, 2013.
19. Goi T, Fujioka M, Satoh Y, Tabata S, Koneri K, Nagano H, Hirono Y, Katayama K, Hirose K, Yamaguchi A. Angiogenesis and tumor proliferation/ metastasis of human colorectal cancer cell line sw620 transfected with endocrine glands-derived-vascular endothelial growth factor, as a new angiogenic factor. Cancer Res 64: 1906–1910, 2004.
20. Guo W, Keckesova Z, Donaher JL, Shibue T, Tischler V, Reinhardt F, Itzkovitz S, Noske A, Zurrer-Hardi U, Bell G, Tam WL, Mani SA, van Oudernaarden Weinberg RA. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148: 1015–1028, 2012.
21. Haigis MC, Deng CX, Finley LW, Kim HS, Gius D. SIRT3 is a mitochondrial tumor suppressor: a scientific tale that connects aberrant cellular ROS, the Warburg effect, and carcinogenesis. Cancer Res 72: 2468–2472, 2012.
22. Heath JL, Weiss JM, Lavau CP, Wechsle DS. Iron deprivation in cancer-potential therapeutic implications. Nutrients 5: 2836–2859, 2013.
23. Ho MM, Ng AV, Lam S, Hung JY. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67: 4827–4833, 2007.
24. Jiang L, Nagai H, Ohara H, Hara S, Tachibana M, Hirano S, Shinohara Y, Kohyama N, Akatsuka S, Toyokuni S. Characteristics and modifying factors of asbestos-induced oxidative DNA damage. Cancer Sci 99: 2142–2151, 2008.
25. Jiang SS, Fang WT, Hou YH, Huang SF, Yen BL, Chang JL, Li SM, Liu HP, Liu YL, Huang CT, Li YW, Jang TH, Chan SH, Yang SJ, Hsiung CA, Wu CW, Wang LH, Chang IS. Upregulation of SOX9 in lung adenocarcinoma and its involvement in the regulation of cell growth and tumorigenicity. Clin Cancer Res 16: 4363–4373, 2010.
26. Juntilla MM, Patil VD, Calamito M, Joshi RP, Birnbaum MJ, Koretzky GA. AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species. Blood 115: 4030–4038, 2010.
27. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420–1428, 2009.
28. Kanai Y, Hiramatsu R, Matoba S, Kidokoro T. From SRY to SOX9: mammalian testis differentiation. J Biochem 138: 13–19, 2005.
29. Kim JL, Kang HN, Kang MH, Yoo YA, Kim JS, Choi CW. The oral iron chelator deferasirox induces apoptosis in myeloid leukemia cells by targeting caspase. Acta Haematol 126: 241–245, 2011.
30. Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AR. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One 3: e3077, 2008.
31. Levina V, Marrangoni A, Wang T, Parikh S, Su Y, Herberman R, Lokshin A, Gorelik E. Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop. Cancer Res 70: 338–46, 2010.
32. Lü B, Fang Y, Xu J, Wang L, Xu F, Xu E, Huang Q, Lai M. Analysis of SOX9 expression in colorectal cancer. Am J Clin Pathol 130: 897–904, 2008.
33. Luanpitpong S, Talbott SJ, Rojanasakul Y, Nimmannit U, Pongrakhananon V, Wang L, Chanvorachote P. Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1. J Biol Chem 285: 38832–38840, 2010.
34. Luanpitpong S, Nimmannit U, Chanvorachote P, Leonard SS, Pongrakhananon V, Wang L, Rojanasakul Y. Hydroxyl radical mediates cisplatin-induced apoptosis in human hair follicle dermal papilla cells and keratinocytes through Bcl-2-dependent mechanism. Apoptosis 16: 769–782, 2011.
35. Luanpitpong S, Wang L, Stueckle TA, Tse W, Chen YC, Rojanasakul Y. Caveolin-1 regulates lung cancer stem-like cell induction and p53 inactivation in carbon nanotube-driven tumorigenesis. Oncotarget 5: 3541–3554, 2014.
36. Luanpitpong S, Li J, Manke A, Brundage K, Ellis E, McLaughlin S, Angsutararux P, Chanthra N, Voronkova M, Chen YC, Wang L, Chanvorachote P, Pei M, Issaragrisil S, Rojanasakul Y. SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma. Oncogene [Epub ahead of print].
37. Mani SA, Guo W, Liao MJ, Ng E, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704–715, 2008.
38. Matheu A, Collado M, Wise C, Manterola L, Cekaite L, Tye AJ, Canamero M, Bujanda L, Schedl A, Cheah KS, Skotheim RI, Lothe RA, López de Munain A, Briscoe J, Serrano M, Lovell-Badge R. Oncogenicity of the developmental transcription factor Sox9. Cancer Res 72: 1301–1315, 2012.
39. May CD, Sphyris N, Evans KW, Werden SJ, Guo W, Mani SA. Epithelial-mesenchymal transition and cancer stem cells: A dangerously dynamic duo in breast cancer progression. Breast Cancer Res 13: 202, 2011.
40. McDonald A, McDonald J, Pooley F. Mineral fibre content of lung in mesothelial tumours in North America. Ann Occup Hyg 26: 417–422, 1982.
41. Nurwidya F, Takahashi F, Murakami A, Takahashi K. Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer. Cancer Res Treat 44: 151–156, 2012.
42. Passeron T, Valencia JC, Namiki T, Vieira WD, Passeron H, Miyamura Y, Hearing VJ. Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid. J Clin Invest 1194: 954–963, 2009.
43. Perona R, Lopez-Ayllon BD, Castro Carpeno J, Belda-Iniesta C. A role for cancer stem cells in drug resistance and metastasis in non-smallcell lung cancer. Clin Transl Oncol 13: 289–293, 2011.
44. Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med 19: 1423–1437, 2013.
45. Rybak AP, Tang D. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells. Cell Signal 25: 2734–2742, 2013.
46. Setsukinai K, Urano Y, Kakinuma K, Majima HJ, Nagano T. Development of novel fluorescence probes than can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem 278: 3170–3175, 2003.
47. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 63: 11–30, 2013.
48. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, Sabatini DM, Chen IS, Hahn WC, Sharp PA, Weinberg RA, Novina CD. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9: 493–501, 2003.
49. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 139: 871–890, 2009.
50. Torti SV, Torti FM. Iron and cancer: more ore to be mined. Nat Rev Cancer 13: 342–355, 2013.
51. Tsai JH, Yang J. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev 27: 2192–2206, 2013.
52. Turcatel G, Rubin N, Menke DB, Martin G, Shi W, Warburton D. Lung mesenchymal expression of Sox9 plays a critical role in tracheal development. BMC Biol 11: 117, 2013.
53. Westerink RH, Vijverberg HP. Vesicular catecholamine release from rat PC12 cells on acute and subchronic exposure to polychlorinated biphenyls. Toxicol Appl Pharmacol 183: 153–159, 2002.
54. Wolkow N, Li Y, Maminishkis A, Song Y, Alekseev O, Iacovelli J, Song D, Lee JC, Dunaief JL. Iron upregulates melanogenesis in cultured retinal pigment epithelial cells. Exp Eye Res 128: 92–101, 2014.